Episode 40 - Talking Hemophilia: Evolving Frontiers in Hemophilia Treatment: Patient-Focused Strategies to Improve Outcomes - Part 2: Clinical Evidence on Novel Therapy Options in Hemophilia

There has been unprecedented research progress in the treatment of hemophilia heralded by the development of non-replacement therapies, emerging factor mimetics, and novel gene therapy agents. In this podcast series, Dr. Jonathan C. Roberts and Dr. Mindy Simpson inform and guide on safely integrating recently approved agents into the treatment continuum while ensuring alignment with critical new breakthroughs and enabling patient-focused care pathways.Launch Date: February 4, 2025Release Date: February 4, 2025Expiration Date: January 31, 2026FACULTYJonathan C. Roberts, MDAssociate Medical DirectorAssociate Research DirectorBleeding and Clotting Disorders InstituteAssociate Professor of Pediatrics and MedicineUniversity of Illinois College of Medicine at PeoriaMindy Simpson, MDMedical DirectorRush Hemophilia and Thrombophilia CenterAssistant Professor of Pediatrics in Pediatric Hematology/OncologyRush University Medical CenterThis podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information here prior to listening to this episode.